Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring (DG3)

This study has been completed.
Eli Lilly and Company
Information provided by (Responsible Party):
Jean-Luc Ardilouze, Université de Sherbrooke Identifier:
First received: November 17, 2011
Last updated: June 14, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)